Putting evidence in to practice®: Evidence-based interventions for cancer-related dyspnea

Clinical Journal of Oncology Nursing

Volumn 12, Issue 2, 2008, Pages 341-352

  Disalvo, Wendye M ^a   Joyce, Margaret M ^b,c   Tyson, Leslie B ^d   Culkin, Ann E ^d   Mackay, Kathleen ^e  

^a NORRIS COTTON CANCER CENTER   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^c UNIVERSITY OF UTAH   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NARCOTIC ANALGESIC AGENT;

COGNITIVE THERAPY; CONSENSUS; DYSPNEA; EVIDENCE BASED MEDICINE; HUMAN; MASS COMMUNICATION; METHODOLOGY; NEOPLASM; NURSE ATTITUDE; NURSING RESEARCH; ONCOLOGY NURSING; ORGANIZATION AND MANAGEMENT; OXYGEN THERAPY; PRACTICE GUIDELINE; QUALITY CONTROL; REVIEW;

ANALGESICS, OPIOID; BENCHMARKING; COGNITIVE THERAPY; CONSENSUS; DIFFUSION OF INNOVATION; DYSPNEA; EVIDENCE-BASED MEDICINE; HUMANS; NEOPLASMS; NURSE'S ROLE; NURSING RESEARCH; ONCOLOGIC NURSING; OXYGEN INHALATION THERAPY; PRACTICE GUIDELINES AS TOPIC; RESEARCH DESIGN;

EID: 45549109569     PISSN: 10921095     EISSN: 1538067X     Source Type: Journal    
DOI: 10.1188/08.CJON.341-352     Document Type: Article

References (27)

1. Jennings, A.L., Davies, A.N., Higgins, J.P., Gibbs, J.S., & Broadley, K.E. (2002). A systematic review of the use of opioids in the management of dyspnoea. Thorax, 57(11), 939-944.
2. Allard, P., Lamontagne, C, Bernard, P., & Tremblay, C. (1999). How effective are supplementary doses of opioids for dyspnea in terminally ill cancer patients? A randomized continuous sequential clinical trial. Journal of Pain and Symptom Management, 17(4), 256-265.
3. Mazzocato, C, Buclin, T., & Rapin, C.H. (1999). The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: A randomized double-blind controlled trial. Annals of Oncology, 10(12), 1511-1514.
4. Bruera, E., Macmillan, K., Pither, J., & MacDonald, R.N. (1990). Effects of morphine on the dyspnea of terminal cancer patients. Journal of Pain and Symptom Management, 5(6), 341-344.
5. National Comprehensive Cancer Network. (2006). Clinical practice guidelines in oncology: Palliative care, version 1.2006. Retrieved January 18, 2007, from http://www.nccn.org/professionals/physician_gls/PDF/palliative.pdf
6. Bruera, E., de Stoutz, N., Velasco-Leiva, A., Schoeller, T., & Hanson, J. (1993). Effects of oxygen on dyspnea in hypoxaemic terminal-cancer patients. Lancet, 342(8862), 13-14.
7. Bruera, E., Sweeney, C, Willey, J., Palmer, J.L., Strasser, F., Morice, R.C., et al. (2003). Randomized controlled trial of supplemental oxygen versus air in cancer patients with dyspnea. Palliative Medicine, 17(8), 659-663.
8. Boyd, K.J., & Kelly, M. (1997). Oral morphine as symptomatic treatment of dyspnea in patients with advanced cancer. Palliative Medicine, 11(4), 277-281.
9. Navigante, A.H., Cerchietti, L.C., Castro, M.A., Lutteral, M.A., & Cabalar, M.E. (2006). Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer. Journal of Pain and Symptom Management, 31(1), 38-47.
10. Coyne, P.J., Viswanathan, R., & Smith, T.J. (2002). Nebulized fentanyl citrate improves patients' perception of breathing, respiratory rate, and oxygen saturation in dyspnea. Journal of Pain and Symptom Management, 23(2), 157-160.
11. Shimoyama, N., & Shimoyama, M. (2002). Nebulized furosemide as a novel treatment for dyspnea in terminal cancer patients. Journal of Pain and Symptom Management, 23(1), 73-76.
12. Kohara, H., Ueoka, H., Maeda, T., Takeyama, H., Saito, R., Shima, Y, et al. (2003). Effects of nebulized furosemide in terminally ill cancer patients with dyspnea. Journal of Pain and Symptom Management, 26(4), 962-967.
13. Wilcock, A., Corcoran, R., & Tattersfeld, A.E. (1994). Safety and efficacy of nebulized lignocaine in patients with cancer and breathlessness. Palliative Medicine, 8(1), 35-38.
14. Joyce, M., McSweeney, M., Carrieri-Kohlnman, K.L., & Hawkins, J. (2004). The use of nebulized opioids in the management of dyspnea: Evidence synthesis. Oncology Nursing Forum, 31(3), 551-561.
15. Bruera, E., Sala, R., Spruyt, O., Palmer, J.L., Zhang, T., & Willey, J. (2005). Nebulized versus subcutaneous morphine for patients with cancer dyspnea: A preliminary study. Journal of Pain and Symptom Management, 29(6), 613-618.
16. Quigley, C, Joel, S., Patel, N., Baksh, A., & Slevin, M. (2002). A phase I/II study of nebulized morphine-6-glucuronide in patients with cancer related breathlessness. Journal of Pain and Symptom Management, 23(1), 7-9.
17. Tanaka, K., Shima, Y, Kakinuma, R., Kubota, K., Ohe, Y, Hojo, F., et al. (1999). Effect of nebulized morphine in cancer patients with dyspnea: A pilot study. Japanese Journal of Clinical Oncology, 29(12), 600-603.
18. Zeppetella, G. (1997). Nebulized morphine in the palliation of dyspnoea. Palliative Medicine, 11(4), 267-275.
19. American Thoracic Society. (1999). Dyspnea. Mechanisms, assessment, and management: A consensus statement. American Journal of Respiratory and Critical Care Medicine, 159(1), 321-340.
20. Ahmedzai, S.H., Laude, E., Robertson, A., Troy, G., & Vora, V. (2004). A double blind, randomized, controlled phase II trial of heliox 28 gas mixture in lung cancer patients with dyspnoea on exertion. British Journal of Cancer, 90(2), 366-371.
21. Filshie, J., Penn, K., Ashley, S., & Davis, C.L. (1996). Acupuncture for the relief of cancer related breathlessness. Palliative Medicine, 10(2), 145-150.
22. Bredin, M., Corner, J., Krishnasamy, M., Plant, H., Bailey, C, & A'Hern, R. (1999). Multicenter randomized controlled trial of nursing intervention for breathlessness in patients with lung cancer. BMJ, 318(7188), 901-904.
23. Corner, J., Plant, H., A'Hern, R., & Bailey, C. (1996). Non-pharmacological intervention for breathlessness in lung cancer. Palliative Medicine, 10(4), 299-305.
24. Hately, J., Laurence, V., Scott, A., Baker, R., & Thomas, P. (2003). Breathlessness clinics within specialist palliative care settings can improve the quality of life and functional capacity of patients with lung cancer. Palliative Medicine, 17(5), 410-417.
25. Campbell, M.L. (2004). Terminal dyspnea and respiratory distress. Critical Care Clinics, 20(3), 403-417.
26. Dudgeon, D.J. (2002). Managing dyspnea and cough. Hematology/Oncology Clinics of North America, 16(3), 557-577.
27. Gallo-Silver, L, & Pollack, B. (2000). Behavioral interventions for lung cancer-related breathlessness. Cancer Practice, 8(6), 268-273.